Is creatine supplementation appropriate for a woman with endometriosis?

Creatine Supplementation Should Be Avoided in Women with Endometriosis

Women with endometriosis should not take creatine supplements, as recent mechanistic research demonstrates that creatine directly promotes disease progression through multiple pathways including macrophage polarization, ferroptosis resistance, and enhanced lesion angiogenesis.

Primary Evidence Against Creatine Use

The most compelling evidence comes from two high-quality mechanistic studies published in 2024-2025:

• Creatine accumulates abnormally in peritoneal fluid and ectopic endometrial stromal cells of women with endometriosis and directly drives disease pathology 1, 2

• Creatine induces M2 polarization of peritoneal macrophages, which promotes angiogenesis, fibrogenesis, cell adhesion, and tissue repair—all processes that facilitate endometriotic lesion establishment and growth 1

• Creatine supplementation enhances ferroptosis resistance in ectopic endometrial stromal cells by binding to prion protein (PrP), reducing cellular iron concentrations, and decreasing oxidative stress, thereby allowing abnormal cells to survive in the high-iron peritoneal environment 2

• Co-culture experiments demonstrate that creatine-treated macrophages directly promote migration and fibrogenesis of endometrial stromal cells and enhance angiogenesis of endothelial cells in vitro 1

Guideline-Based Treatment Framework

Current ACOG guidelines do not include dietary supplements as standard primary treatments for endometriosis and explicitly caution that supplements should not replace established medical therapy 3

First-line pharmacologic options include:

• GnRH agonists (minimum 3 months) or danazol (minimum 6 months) for moderate-to-severe endometriosis-related pain 3

Second-line/adjunct options include:

• Oral contraceptives, progestins (oral medroxyprogesterone acetate or depot formulations), and NSAIDs 3

Clinical Reasoning

While general creatine safety data in women shows no serious adverse events or increased risk of total adverse outcomes 4, and creatine may offer benefits in other female populations 5, these safety studies were not conducted in women with endometriosis and did not assess disease-specific outcomes.

The mechanistic evidence is particularly strong because:

• Both studies used patient-derived samples showing elevated endogenous creatine synthesis 1, 2
• Multiple complementary pathways were identified (immune modulation, ferroptosis resistance) 1, 2
• In vitro functional assays directly demonstrated pro-disease effects 1, 2

Important Caveats

• Nutritional supplements in general have shown mixed results for endometriosis-related pain, with some vitamins, fatty acids, and bioactive compounds demonstrating benefit in small studies 6—however, creatine was not among the supplements studied in pain trials

• Cardiovascular considerations: Women with endometriosis already face increased cardiovascular disease risk (pooled RR 1.16 for composite CVD) 7, making it particularly important to avoid supplements that might promote inflammatory pathways

• No fertility benefit: Current evidence does not demonstrate that dietary supplement use affects future fertility in women with endometriosis 3

Practical Recommendation Algorithm

For any woman with confirmed or suspected endometriosis:

1. Discontinue creatine supplementation if currently taking
2. Initiate or optimize guideline-based hormonal therapy (progestins, GnRH agonists, or oral contraceptives) 3
3. Add NSAIDs for pain control as needed 3
4. Consider surgical excision only when pain persists despite optimal medical therapy 3
5. If considering adjunctive nutritional approaches, discuss evidence-based options such as omega-3 fatty acids or specific antioxidants rather than creatine 6